Early infectious complications among patients treated with induction compared to hypomethylating therapy for acute myeloid leukemia

Leuk Lymphoma. 2018 Apr;59(4):988-991. doi: 10.1080/10428194.2017.1361028. Epub 2017 Aug 9.

Authors

Marla M Jalbut^{1

2}, Andrew M Brunner¹, Philip C Amrein¹, Karen K Ballen¹, Gabriela S Hobbs¹, Ashley M Perry¹, Christelle P Joseph¹, Amir T Fathi¹

Affiliations

¹ a Division of Hematology/Oncology , Massachusetts General Hospital, Harvard Medical School , Boston , MA , USA.
² b Tufts University School of Medicine , Boston , MA , USA.

No abstract available

Publication types

Comparative Study
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Age Factors
Aged
Antibiotic Prophylaxis / methods
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Chemotherapy-Induced Febrile Neutropenia / epidemiology*
Chemotherapy-Induced Febrile Neutropenia / immunology
Communicable Diseases / epidemiology*
Communicable Diseases / immunology
Communicable Diseases / microbiology
DNA Methylation / drug effects
Enzyme Inhibitors / adverse effects*
Enzyme Inhibitors / therapeutic use
Female
Humans
Immunosuppression Therapy / adverse effects
Immunosuppression Therapy / methods
Incidence
Leukemia, Myeloid, Acute / drug therapy*
Leukemia, Myeloid, Acute / genetics
Male
Middle Aged
Remission Induction / methods
Retrospective Studies
Young Adult

Substances

Enzyme Inhibitors

Grants and funding